AzTrials
AzTrials

AnxietyNCT02837016

Biofeedback-aided Intervention for Self-regulation

A study testing Wearable biofeedback and Relaxation Treatment in people with Anxiety, run by Texas A&M University at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The investigators propose a randomized controlled trial (RCT) to investigate the feasibility and efficacy of non-intrusive biofeedback devices that can be worn throughout the day in providing therapeutic cues to college students suffering from chronic anxiety. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Anxiety
What is being tested?
Wearable biofeedback and Relaxation Treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteUnited States
Study dates
Jul 2016to Jul 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • students,
  • self-reported chronic anxiety

Who cannot join

  • Attention Deficit Hyperactive Disorder
  • no major psychiatric disorder ( depression/anxiety okay)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Texas A&M Univeristy

    College Station, Texas, 77840

Other trials in United States

About this study

The investigators propose a randomized controlled trial (RCT) to investigate the feasibility and efficacy of non-intrusive biofeedback devices that can be worn throughout the day in providing therapeutic cues to college students suffering from chronic anxiety. The biofeedback device detects physiological stress indices in real time (e.g., changes in breathing rate) and provides feedback (e.g., through minor vibration or text messages) serving as a cue to the wearer to recall therapeutic steps at exactly those moments they need to exert cognitive control. Students will be randomized in a 1) experimental group with biofeedback device and 2) experimental group without biofeedback device. Experimental groups will undergo an intervention that will strengthening cognitive control through mindfulness-based relaxation techniques. Outcome measures will include a multi-method approach collecting questionnaire, behavioral, and psycho-physiological indices of anxiety and self-control. The proposed study is innovative and has the potential to lead to more effective and cost-efficient types of intervention applications in the future.

Read the detailed description

Fourty participants will be tested in approximately 2 groups of 20 each. After individual first lab visits, participants in each cohort will be randomized into two groups: two experimental groups. The experimental group will subsequently attend a group-based relaxation treatment based on mindfulness meditation principles. After this intervention, one of the experimental groups will use the biofeedback device in the next two weeks, whereas the other experimental group will not. Both the biofeedback and No-Biofeedback group will receive texts on a daily basis.

During the lab session, participants will sign informed consent and fill out questionnaires. Questionnaires used will be:

  • Difficulties in Emotion Regulation Scale
  • State-Trait Anxiety Inventory
  • Perceived Stress Scale
  • Patient Health Questionnaire
  • Sleep Scale from the Medical Outcomes Study
  • and a constructed questionnaire about social support ( family \& friends)

After that, participants are being hooked up to the ECG and Psychophysiological measures for a Stroop task (identify color of the word). The design will utilize a 1 min congruent task, followed by a 2 minute relaxation period, then a 1 min in-congruent task, followed up a 2 min relaxation period, then another 1 min congruent task, followed by a final 2 minute relaxation period. After that, participants will be deceived to think they will have to give a speech task in front of 5 evaluators. We will, however, inform participants of technical difficulties, resulting in our inability to follow through with the task, then again give the 2 minutes to regulate their physiology. Lab sessions, including set-up, should take about 45 minutes. After the testing section, all physiological measures will be removed and RAs will review meditation/ relaxation strategies with the participant. This relaxation training session will take about thirty minutes. After that, the biofeedback group will be given the biofeedback device as well as instruction on how to pair the device with their phone. After that, participants are free to leave.

The same lab procedures are being followed for the second lab visit after, approximately, two weeks without the relaxation session.

Conditions
Anxiety
Being tested
Wearable biofeedback, Relaxation Treatment
Keywords
Self-Control, Biofeedback, Respiration
Medical subject headings
Anxiety Disorders, Self-Control, Respiratory Aspiration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Wearable biofeedbackDevice

  • Relaxation TreatmentBehavioural

    group-based relaxation treatment based on mindfulness meditation principles

Study groups in NCT02837016
Study groupRoleWhat they receive
Experimental 1ExperimentalWearable biofeedback device + Relaxation Training
Receives: Device: Wearable biofeedback; Behavioral: Relaxation Treatment
Experimental 2Active comparatorRelaxation Training only
Receives: Behavioral: Relaxation Treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. State/Trait Anxiety Scale

    State Trait Anxiety Index (STAI); Spielberger, Gorsuch, Lushene, Vagg, \& Jacobs, 1983

    Measured: 2 weeks

  2. Difficulties in Emotion Regulation Scale

    Difficulties in Emotion Regulation (DERS); Gratz \& Roemer, 2004

    Measured: 2 weeks

  3. Heart Rate

    Using Biopac

    Measured: 2 weeks

  4. Heart Rate Reactivity

    Using Biopac

    Measured: 2 weeks

  5. Respiratory Sinus Arrithmiya

    Using Biopac

    Measured: 2 weeks

  6. Perceived Stress Scale

    Perceived Stress Scale; Cohen, Kamarack, \& Mermelstein, 1983

    Measured: 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jul 2016 (estimated)
  2. Study startJul 2016
  3. Primary completionJul 2019 (estimated)
  4. Study completionJul 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02837016
Sponsor's protocol ID
IRB2015-0786D
Status last verified
Apr 2018
First submitted
13 Jul 2016
Last updated
26 Apr 2018
Results posted
No
Data monitoring committee
No

Publications

  • Lin B, Prickett C, Woltering S. Feasibility of using a biofeedback device in mindfulness training - a pilot randomized controlled trial. Pilot Feasibility Stud. 2021 Mar 24;7(1):84. doi: 10.1186/s40814-021-00807-1.

    PubMed 33762016

Questions about this trial

What is this clinical trial studying?

A study testing Wearable biofeedback and Relaxation Treatment in people with Anxiety, run by Texas A&M University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Apr 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

State/Trait Anxiety Scale (time frame: 2 weeks). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02837016, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Apr 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in